Health Care Services

CVS Health

Gamco Investors Reduces CVS Health Stake by 11.6% and Sells Nearly 15,000 Shares

North Dakota Investment Board Increases CVS Holdings as Q1 Earnings Beat Expectations

CVS Health Joins CNCF as Platinum Member to Optimize Tech Architecture

DNB Asset Management Increases CVS Stake by 17.6%, Analysts Upgrade to Buy

World Investment Advisory and others significantly increase CVS Health holdings as earnings beat expectations

CVS Health Corporation's average stock price target raised to $100.12

CVS Health Wins Dual AI Awards at the 2026 Stevie Awards

Bernstein Raises CVS Health Target Price to $106

CVS Health's EVP Tilak Mandadi sells company stocks

Mizuho Analyst Reiterates Buy Rating on CVS Health With Price Target

Swiss Bank Raises CVS Health's Target Price to $100 and Maintains Buy Rating

CVS Health and Hartford HealthCare Partner to Offer Adult Primary Care Services

Barclays analyst maintains buy rating on CVS Health

CVS Health's Lower Medical Cost Ratio Lifts Profit and Outlook

CVS Health released FY2026 Q1 earnings on May 6 Pre-Market (EST), actual revenue USD 99.85 B (forecast USD 95.02 B), actual EPS USD 2.3 (forecast USD 1.9251)

CVS Health Executives Report Customers Halting Coverage for GLP-1 Drugs

Cvs Announces Expansion of Biosimilar Drug Use

CVS Health Adjusts Prescription Drug List to Lower Costs

Strs Ohio Reduces Holdings in CVS Health

CVS Builds First Highly Automated Warehouse

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Pinned News

置顶新闻

Gamco Investors INC. ET AL Sells 14,768 Shares of CVS Health Corporation $CVS

CVS Health Corporation (CVS.US) Q1 2026 Earnings Conference Call

CVS Health Corporation (CVS.US) Q4 2025 Earnings Conference Call

CVS Health Corporation (CVS.US) Q2 2025 Earnings Conference Call

CVS Health Corporation (CVS.US) Q1 2025 Earnings Conference Call

CVS Health Corporation (CVS.US) 2024 Q4 Earnings Conference Call

Gamco Investors INC. ET AL reduced its stake in CVS Health Corporation by 11.6%, selling 14,768 shares during the 4th quarter. After the sale, it holds 112,713 shares valued at approximately $8.95 million. Other institutional investors have also adjusted their positions in CVS Health, with significant increases noted. CVS Health's stock has a consensus rating of 'Moderate Buy' with an average price target of $98.08.

Market Beat

GAMCO Investors, Inc.

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

ABBV

AbbVie and CVS Health appear expensive with trailing P/E multiples over 40, but non-recurring expenses inflate these figures. AbbVie’s forward P/E is 15, while CVS Health’s is 13, indicating they may be undervalued. AbbVie faced a significant drop in net income due to a $2.7 billion charge, while CVS reported a $4 billion loss from goodwill impairment. Both companies show potential for better performance, making them attractive investment options despite their current valuations.

nasdaq

Abbvie

VanEck Biotech ETF

SPDR S&P Biotech

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Health Care Select Sector SPDR

iShares Global Healthcare

Invesco Nasdaq Biotechnology ETF

iShares US Pharma

VG Health

NVIDIA

Intel

S&P 500

NVIDIA Corporation

2 Stocks That Are Much Cheaper Than They Look

Bill Allison, a 65-year-old military veteran, underwent a heart transplant after two heart attacks and years of smoking. With support from his CVS Specialty pharmacist, he made significant lifestyle changes and emphasizes the importance of medication adherence and ongoing care. Now 81, he advocates for organ donation and encourages others to listen to their healthcare teams for a second chance at life.

MorningStar

CVS Health: A Second Chance at Life Through Heart Transplant and Ongoing Care

The majority of participants in a recent survey expressed that their limited digital literacy skills are affecting their health management negatively. CVS Health is actively introducing new digital tools to assist members in accessing medical services. This effort is part of the company's massive $20 billion technology plan revealed in 2025.

Unusual Whales

CVS Health study reveals a need for greater digital health literacy for Medicare members

North Dakota State Investment Board acquired 43,833 shares of CVS Health Corporation (NYSE:CVS) valued at approximately $3.48 million in Q4, according to SEC filings. Other institutional investors have also adjusted their stakes in CVS. Analysts have given CVS a 'Moderate Buy' rating, with target prices ranging from $92 to $106. CVS reported Q1 earnings of $2.57 per share, exceeding estimates, and revenue of $100.43 billion, up 6.2% year-over-year.

Deutsche Bank AG

Goldman Sachs

Bank of America

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

GS Hldg R

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

43,833 Shares in CVS Health Corporation $CVS Purchased by North Dakota State Investment Board

CVS Health has joined the Cloud Native Computing Foundation (CNCF) as a platinum member, enhancing its commitment to secure healthcare and modernization. This membership allows CVS Health to contribute its expertise in cloud infrastructure and serve on the CNCF governing board, guiding the strategic direction of the cloud native ecosystem. The company aims to optimize its technology stack to better serve patients while ensuring trust and efficiency in its services.

Fidelity

CNCF Welcomes CVS Health as a Platinum Member To Expand Cloud Native Collaboration

DNB Asset Management AS increased its holdings in CVS Health Corporation by 17.6% in Q4, owning 446,843 shares valued at $35.46 million. Other institutional investors also raised their stakes. Analysts have set new price targets for CVS, with many rating it as a 'buy'. CVS Health's stock opened at $95.95, with a market cap of $122.42 billion and a P/E ratio of 42.27.

State Street

Invesco

State Street® US Equity Premium Inc ETF

DNB Asset Management AS Grows Holdings in CVS Health Corporation $CVS

CVS Health Corp. shares fell 1.30% to $95.89 on Friday, marking the second consecutive day of losses. The stock is 2.58% below its 52-week high of $98.43. In comparison, competitors like Amazon, UnitedHealth, and Elevance also experienced declines. Trading volume reached 8.8 million, surpassing the 50-day average of 8.1 million.

MarketWatch Automated

Dow Jones Industrial Average

Amazon

Unitedhealth

Elevance Health

Factset Research

CVS Health Corp. Stock Underperforms Friday When Compared To Competitors

CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide | CVS Stock News

StockTitan

CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide | CVS Stock News

World Investment Advisors increased its holdings in CVS Health Corporation by 36.5% in Q4, owning 73,409 shares valued at $5.83 million. Other institutional investors also raised their stakes, with notable increases from Caitong International and Dogwood Wealth Management. CVS Health's stock opened at $98.14, with a market cap of $125.22 billion and a P/E ratio of 43.24. The company reported a quarterly EPS of $2.57, exceeding estimates, and announced a dividend of $0.665 per share. Analysts maintain a consensus rating of "Moderate Buy" with an average price target of $97.00.

Barclays

World Investment Advisors Grows Position in CVS Health Corporation $CVS

CVS Health(CVS.US)

Gamco Investors INC. ET AL Sells 14,768 Shares of CVS Health Corporation $CVS

2 Stocks That Are Much Cheaper Than They Look

CVS Health: A Second Chance at Life Through Heart Transplant and Ongoing Care

CVS Health study reveals a need for greater digital health literacy for Medicare members

43,833 Shares in CVS Health Corporation $CVS Purchased by North Dakota State Investment Board

CNCF Welcomes CVS Health as a Platinum Member To Expand Cloud Native Collaboration

DNB Asset Management AS Grows Holdings in CVS Health Corporation $CVS

CVS Health Corp. Stock Underperforms Friday When Compared To Competitors

CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide | CVS Stock News

World Investment Advisors Grows Position in CVS Health Corporation $CVS

Trending